
Masimo (MASI) Stock Forecast & Price Target
Masimo (MASI) Analyst Ratings
Bulls say
Masimo Corp is poised for robust growth driven by an increase in both its core SET pulse oximetry business and advanced monitoring parameters, supported by successful new product launches and expanded market share. The company is expected to achieve consistent EBIT margin increases, projecting a rise to approximately 29.2% and 29.8% in FY26 and FY27, respectively. Anticipated revenue growth is further bolstered by expected acceleration in the latter years due to the meaningful contributions of new product launches and strong performance in both domestic and international markets.
Bears say
Masimo Corp anticipates a significant negative impact from tariffs in FY25, estimating a $16 million to $17 million decrease that could affect operating margins by approximately 110 basis points. Additionally, the company faces numerous risks, including increased competition, pricing pressures, and potential delays in regulatory approvals and product launches, all of which could hinder growth and profitability. The combination of these challenges, along with unpredictable revenue due to variable order and installation timelines, contributes to a cautious outlook on Masimo's financial performance.
This aggregate rating is based on analysts' research of Masimo and is not a guaranteed prediction by Public.com or investment advice.
Masimo (MASI) Analyst Forecast & Price Prediction
Start investing in Masimo (MASI)
Order type
Buy in
Order amount
Est. shares
0 shares